SOLENO THERAPEUTICS INC short interest in 2020
In 2020, SOLENO THERAPEUTICS INC's disclosed short interest ran from 0.22% of shares outstanding on 31 Jan 2020 to 1.25% on 31 Dec 2020, a change of +1.03 percentage points. The year's high was 2.26% on 14 Aug 2020 and its low 0.21% on 13 Mar 2020, averaging 1.05% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.46 days on 30 Nov 2020. Full history: SOLENO THERAPEUTICS INC.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 0.22% (31 Jan 2020)
- End of year
- 1.25% (31 Dec 2020)
- Change
- +1.03 pp
- High
- 2.26% (14 Aug 2020)
- Low
- 0.21% (13 Mar 2020)
- Average
- 1.05%
- Highest days to cover
- 6.46 (30 Nov 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Jan 2020 | 0.22% | 1.00 | |
| 14 Feb 2020 | 0.31% | 1.30 | |
| 28 Feb 2020 | 0.27% | 1.01 | |
| 13 Mar 2020 | 0.21% | 1.00 | 10-K filed, results (8-K) |
| 31 Mar 2020 | 0.26% | 1.37 | |
| 15 Apr 2020 | 0.22% | 1.11 | |
| 30 Apr 2020 | 0.32% | 1.30 | |
| 14 Aug 2020 | 2.26% | 4.99 | 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Aug 2020 | 1.95% | 2.80 | |
| 15 Sep 2020 | 1.75% | 2.59 | |
| 30 Sep 2020 | 2.03% | 2.26 | |
| 15 Oct 2020 | 1.67% | 2.67 | |
| 30 Oct 2020 | 1.30% | 3.84 | |
| 13 Nov 2020 | 1.30% | 4.01 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 1.27% | 6.46 | |
| 15 Dec 2020 | 1.24% | 5.12 | |
| 31 Dec 2020 | 1.25% | 4.71 |
See also: SOLENO THERAPEUTICS INC's full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.